Adrian Gottschalk
Chief Executive Officer en FOGHORN THERAPEUTICS INC. .
Fortuna: 3 M $ al 31/03/2024
Perfil
Adrian Gottschalk is the President, Chief Executive Officer & Director at Foghorn Therapeutics, Inc. He was previously the SVP & Head-Neurodegeneration Therapeutic Area at Biogen, Inc. Mr. Gottschalk received his undergraduate degree from Texas A&M University in 1997, his graduate degree from Harvard Medical School in 2004, and his MBA from MIT Sloan School of Management in 2003.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 29/02/2024 | 511 704 ( 1.20% ) | 3 M $ | 31/03/2024 |
Cargos activos de Adrian Gottschalk
| Empresas | Cargo | Inicio |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Chief Executive Officer | 01/05/2017 |
Antiguos cargos conocidos de Adrian Gottschalk.
| Empresas | Cargo | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/05/2017 |
Formación de Adrian Gottschalk.
| Texas A&M University | Undergraduate Degree |
| Harvard Medical School | Graduate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| FOGHORN THERAPEUTICS INC. | Health Technology |
- Bolsa de valores
- Insiders
- Adrian Gottschalk
